Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
38147
CAS Number:
144689-63-4
Olmésartan médoxomil
Purity:
≥ 98 % (dosage par titration, HPLC)
Synonym(s):
Ester méthylique de l'acide 4-(1-hydroxy-1-méthyléthyl)-2-propyl-1-[[2'-(2 H -tétrazol-5-yl)[1,1'-biphényl]-4-yl]méthyl]-1 H -imidazole-5-carboxylique (5-méthyl-2-oxo-1,3-dioxol-4-yl)
Documents
$145.52 /1G
Taille
Request Bulk Quote
Informations sur le produit

Olmesartan medoxomil is a potent angiotensin II receptor antagonist, primarily utilized in the treatment of hypertension. This compound is recognized for its ability to effectively lower blood pressure by inhibiting the action of angiotensin II, a hormone that constricts blood vessels. Its unique structure allows for enhanced bioavailability and a prolonged duration of action, making it a preferred choice among healthcare professionals. Olmesartan medoxomil is often prescribed in combination with other antihypertensive agents, providing a synergistic effect that can lead to improved patient outcomes.

In addition to its primary use in managing high blood pressure, Olmesartan medoxomil has shown potential in the treatment of heart failure and chronic kidney disease, where blood pressure control is crucial. Its favorable side effect profile and efficacy make it a valuable option in clinical settings. Researchers are also exploring its applications in other cardiovascular conditions, highlighting its versatility and importance in modern medicine. With its established track record, Olmesartan medoxomil continues to be a significant player in the pharmaceutical landscape.

Numéro CAS 
144689-63-4
Formule moléculaire
C29H30N6O6
Poids moléculaire 
558.6
Point de fusion 
180 °C (déc.)
Informations générales
Numéro CAS 
144689-63-4
Formule moléculaire
C29H30N6O6
Poids moléculaire 
558.6
Point de fusion 
180 °C (déc.)
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

Olmesartan medoxomil is widely utilized in research focused on:

  • Hypertension Management: This compound is primarily used in the treatment of high blood pressure, helping to reduce the risk of heart disease and stroke. Its effectiveness in lowering blood pressure makes it a preferred choice among healthcare providers.
  • Cardiovascular Research: Researchers study its effects on cardiovascular health, examining how it can improve outcomes in patients with heart-related conditions. Clinical trials often explore its long-term benefits and safety profile.
  • Combination Therapies: Olmesartan medoxomil is frequently used in combination with other antihypertensive agents, enhancing overall efficacy and patient compliance. This approach allows for tailored treatment plans based on individual patient needs.
  • Renal Protection Studies: It is also investigated for its protective effects on kidney function, particularly in patients with diabetes or chronic kidney disease. This application is crucial for preventing progression to more severe renal issues.
  • Pharmaceutical Development: The compound serves as a model for developing new antihypertensive medications, inspiring research into similar compounds with improved efficacy and fewer side effects.

Citations